Aurobindo Pharma has acquired a 26% stake in Swarnaakshu Solar Power Private Limited. An initial investment of Rs 0.52 Cr has been made, with the total investment expected to reach up to Rs 10.40 Cr. This strategic acquisition enables Aurobindo Pharma to source solar power for its captive consumption, aligning with Telangana's energy policy. The move aims to enhance energy efficiency, reduce long-term operational costs, and boost sustainability, marking a key step in backward integration for its power needs.